Related Experiment Videos
Insights
Porphyrias are classified by symptoms, distinguishing acute neurological or photosensitive attacks. Diagnosis involves analyzing porphyrin precursors and levels in patients with porphyria.
Area of Science:
- Biochemistry
- Genetics
- Dermatology
Background:
- Porphyrias are a group of genetic disorders characterized by the abnormal production and accumulation of porphyrins.
- These disorders can manifest with a wide range of clinical symptoms, affecting the nervous system and skin.
- Accurate classification and diagnosis are crucial for effective patient management.
Purpose of the Study:
- To provide a comprehensive overview of porphyria classification based on presenting symptoms.
- To highlight key diagnostic markers and laboratory findings for different porphyria types.
- To emphasize the importance of quantitative porphyrin analysis in diagnosis.
Main Methods:
- Clinical symptom-based grouping of porphyrias.
- Identification of characteristic urine and blood porphyrin profiles.
- Review of diagnostic tests including Watson-Schwartz test and quantitative porphyrin analysis.
- Comparison of quantitative analysis with chromatography for diagnostic confirmation.
Main Results:
- Acute porphyrias present with neurological and abdominal symptoms, linked to elevated porphyrin precursors (delta-aminolaevulinic acid, porphobilinogen).
- Photosensitive porphyrias exhibit acute or chronic skin manifestations, with specific porphyrin elevations (protoporphyrins, uroporphyrins) in erythrocytes, urine, or stool.
- Quantitative porphyrin analysis, alongside chromatography, confirms diagnoses across various porphyria subtypes.
Conclusions:
- Symptom presentation is a key factor in porphyria classification, guiding diagnostic approaches.
- Distinct porphyrin profiles in biological samples are essential for differentiating between acute and cutaneous porphyrias.
- Advanced analytical techniques like quantitative porphyrin analysis are vital for accurate diagnosis and management of porphyria patients.
Abstract:
The porphyrias can be grouped conveniently by their presenting symptoms. Acute intermittent neurological symptoms of neuritis, abdominal pain and psychoses may occur in acute intermittent porphyria, hereditary coproporphyria and variegata porphyria. Increase of the porphyrin precursors delta-aminolaevulinic acid and porphobilinogen may be observed in the urine during attacks (Watson-Schwartz test). Patients with acute symptoms of photosensitivity with burning pain and oedema within short exposure periods may have erythropoietic protoporphyria, with high erythrocyte and stool protoporphyrins, erythropoietic coproporphyria, and in the last few years of life the more recently described hepatoerythropoietic porphyria. Symptoms of chronic photosensitivity include; hyperpigmentation, hypertrichosis, easy fragility of the skin with bullae and subsequent scarring in porphyria cutanea tarda (PCT), with increased uroporphyrin in the urine and stool; variegate porphyria with increased protoporphyrin and coproporphyrin in the stool; congenital erythropoietic porphyria with an increased copro- and uroporphyrin (isomer I) in the erythrocytes, urine and stool; and hepatoerythropoietic porphyria in later life, in which the chronic features are similar to PCT. In 1913 Meyer-Betz injected himself with 200 mg haematoporphyrin. Initially, at the higher levels, the symptoms were those of solar urticaria as observed in erythropoietic porphyria, but after several months became identical to PCT. A comparison of quantitative porphyrin analysis (performed on 323 patients with porphyria) and chromatography provides additional confirmation for the diagnosis.